# TuHURA Biosciences, Inc.: filings

HURA · Nasdaq · CIK 1498382 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hura.md) · [Financials](/companies/hura/financials.md) · [Filings](/companies/hura/filings.md) · [Insiders](/companies/hura/insiders.md)

## Reports and events: 346 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 274, 8-K 219, 10-Q 47, CORRESP 37, 425 33, 3 26, UPLOAD 24, EFFECT 22, 424B3 21, S-1/A 21, SC 13G 20, 10-K 15, 424B5 14, SC 13G/A 14, 8-K/A 11, DEF 14A 9, POS AM 8, S-1 8, 424B4 7, PRE 14A 7, S-4/A 7, D 6, S-3 6, SC 13D 6, SC TO-I/A 6, DEFA14A 5, 3/A 4, ARS 4, S-8 4, SC 13D/A 4, 10-K/A 3, 4/A 3, D/A 3, S-4 3, SCHEDULE 13G/A 3, 10-Q/A 2, CT ORDER 2, NT 10-K 2, RW 2, SCHEDULE 13G 2, SC TO-I 2, SEC STAFF LETTER 2, 10-KT 1, 8-A12B 1, 8-A12G 1, CERTNAS 1, NT 10-Q 1, POS EX 1, SC 14F1 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-11-06 | 17:00 ET | [8-K](/filings/0001193125-26-452007.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-452007 |
| 2026-10-16 | 17:00 ET | [8-K](/filings/0001193125-26-424228.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-424228 |
| 2026-09-24 | 17:00 ET | [8-K](/filings/0001193125-26-401140.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-401140 |
| 2026-09-17 | 17:00 ET | [8-K](/filings/0001193125-26-394473.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-394473 |
| 2026-09-17 | 09:00 ET | [8-K/A](/filings/0001193125-26-393847.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-393847 |
| 2026-09-16 | 17:00 ET | [8-K](/filings/0001193125-26-393206.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-393206 |
| 2026-09-04 | 17:00 ET | [8-K](/filings/0001193125-26-383797.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-383797 |
| 2026-08-28 | 18:01 ET | [SCHEDULE 13D/A](/filings/0000897069-26-001732.md) | Ownership report, active investor, amended | 0000897069-26-001732 |
| 2026-08-21 | 17:00 ET | [8-K](/filings/0001193125-26-361272.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-361272 |
| 2026-08-19 | 17:00 ET | [8-K](/filings/0001193125-26-357087.md) | 3.02 Unregistered sale of equity; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-357087 |
| 2026-08-14 | 08:00 ET | [10-Q](/filings/0001193125-26-350451.md) | Quarterly report, period 2026-06-30 | 0001193125-26-350451 |
| 2026-08-14 | 07:50 ET | [8-K](/filings/0001193125-26-350425.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-350425 |
| 2026-08-13 | 17:00 ET | [8-K](/filings/0001193125-26-349540.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-349540 |
| 2026-07-29 | 17:00 ET | [8-K](/filings/0001193125-26-324174.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-324174 |
| 2026-07-09 | 16:05 ET | [DEF 14A](/filings/0001193125-26-299680.md) | Proxy statement, period 2026-08-18 | 0001193125-26-299680 |
| 2026-07-07 | 17:30 ET | [8-K](/filings/0001193125-26-297668.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-297668 |
| 2026-06-17 | 16:30 ET | [8-K](/filings/0001193125-26-274225.md) | 5.08 Item not in the standard list | 0001193125-26-274225 |
| 2026-05-29 | 17:00 ET | [8-K](/filings/0001193125-26-248640.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-248640 |
| 2026-05-15 | 17:20 ET | [10-Q](/filings/0001193125-26-227245.md) | Quarterly report, period 2026-03-31 | 0001193125-26-227245 |
| 2026-05-15 | 17:10 ET | [8-K](/filings/0001193125-26-227204.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-227204 |
| 2026-04-30 | 16:45 ET | [8-K/A](/filings/0001193125-26-197609.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-197609 |
| 2026-04-30 | 16:30 ET | [10-K/A](/filings/0001193125-26-197486.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-197486 |
| 2026-04-22 | 07:40 ET | [8-K](/filings/0001193125-26-168395.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-168395 |
| 2026-04-08 | 16:15 ET | [8-K](/filings/0001193125-26-147660.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-147660 |
| 2026-04-01 | 08:00 ET | [8-K](/filings/0001193125-26-135766.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-135766 |
| 2026-03-31 | 17:15 ET | [10-K](/filings/0001193125-26-134950.md) | Annual report, period 2025-12-31 | 0001193125-26-134950 |
| 2026-01-30 | 16:00 ET | [8-K](/filings/0001193125-26-031742.md) | 3.01 Delisting notice | 0001193125-26-031742 |
| 2025-12-10 | 16:30 ET | [8-K](/filings/0001193125-25-314302.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-314302 |
| 2025-12-05 | 17:00 ET | [8-K](/filings/0001193125-25-309853.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-309853 |
| 2025-11-25 | 08:01 ET | [8-K](/filings/0001193125-25-294581.md) | 7.01 Regulation FD disclosure | 0001193125-25-294581 |
| 2025-11-18 | 17:03 ET | [8-K](/filings/0001193125-25-286419.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-286419 |
| 2025-11-14 | 07:20 ET | [10-Q](/filings/0001193125-25-281539.md) | Quarterly report, period 2025-09-30 | 0001193125-25-281539 |
| 2025-11-14 | 07:10 ET | [8-K](/filings/0001193125-25-281522.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-281522 |
| 2025-11-04 | 07:00 ET | [8-K](/filings/0001193125-25-263523.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-263523 |
| 2025-11-03 | 16:10 ET | [8-K](/filings/0001193125-25-262562.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-262562 |
| 2025-10-31 | 17:00 ET | [8-K](/filings/0001193125-25-260924.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-260924 |
| 2025-09-18 | 16:07 ET | [S-1/A](/filings/0001193125-25-207395.md) | Registration statement, amended | 0001193125-25-207395 |
| 2025-09-11 | 16:30 ET | [8-K](/filings/0000950170-25-114235.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-114235 |
| 2025-08-14 | 16:31 ET | [10-Q](/filings/0000950170-25-108972.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108972 |
| 2025-08-14 | 16:20 ET | [8-K](/filings/0000950170-25-108909.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108909 |
| 2025-08-12 | 16:30 ET | [S-1](/filings/0001193125-25-179009.md) | Registration statement | 0001193125-25-179009 |
| 2025-08-12 | 16:24 ET | [8-K/A](/filings/0001193125-25-178993.md) | 9.01 Financial statements and exhibits | 0001193125-25-178993 |
| 2025-06-30 | 17:00 ET | [8-K](/filings/0000950170-25-091693.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-091693 |
| 2025-06-27 | 18:00 ET | [8-K](/filings/0000950170-25-090522.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-090522 |
| 2025-06-24 | 17:57 ET | [8-K](/filings/0000950170-25-089118.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-089118 |
| 2025-06-12 | 07:00 ET | [8-K](/filings/0000950170-25-085116.md) | 9.01 Financial statements and exhibits | 0000950170-25-085116 |
| 2025-06-06 | 16:42 ET | [8-K](/filings/0001193125-25-137135.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-137135 |
| 2025-05-15 | 16:31 ET | [10-Q](/filings/0000950170-25-072745.md) | Quarterly report, period 2025-03-31 | 0000950170-25-072745 |
| 2025-05-15 | 16:20 ET | [8-K](/filings/0000950170-25-072685.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-072685 |
| 2025-05-07 | 17:00 ET | [8-K/A](/filings/0000950170-25-065860.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-065860 |

Page 1 of 7. [Older](/companies/hura/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 18:07 ET. No prices; not investment advice.